Skip to main content
Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
7.87
-0.12 (-1.50%)
At close: Feb 27, 2026, 4:00 PM EST
7.81
-0.06 (-0.76%)
After-hours: Feb 27, 2026, 7:59 PM EST

Tilray Brands Revenue

Tilray Brands had revenue of $217.51M in the quarter ending November 30, 2025, with 3.11% growth. This brings the company's revenue in the last twelve months to $837.32M, up 0.98% year-over-year. In the fiscal year ending May 31, 2025, Tilray Brands had annual revenue of $821.31M with 4.10% growth.

Revenue (ttm)
$837.32M
Revenue Growth
+0.98%
P/S Ratio
1.10
Revenue / Employee
$294,625
Employees
2,842
Market Cap
916.91M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 31, 2025821.31M32.37M4.10%
May 31, 2024788.94M161.82M25.80%
May 31, 2023627.12M-1.25M-0.20%
May 31, 2022628.37M115.29M22.47%
May 31, 2021513.09M107.76M26.59%
May 31, 2020 Pro Pro Pro
May 31, 2019 Pro Pro Pro
May 31, 2018 Pro Pro Pro
May 31, 2017 Pro Pro Pro
May 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Evotec SE 887.40M
Emergent BioSolutions 788.90M
Collegium Pharmaceutical 757.07M
Amphastar Pharmaceuticals 723.31M
Pacira BioSciences 716.79M
Alvotech 573.35M
Esperion Therapeutics 303.80M
Ironwood Pharmaceuticals 296.15M
Revenue Rankings

TLRY News

More News